scholarly journals How can we make better health decisions a Best Buy for all?

2019 ◽  
Vol 3 ◽  
pp. 1543
Author(s):  
Niki O'Brien ◽  
Ryan Li ◽  
Wanrudee Isaranuwatchai ◽  
Saudamini Vishwanath Dabak ◽  
Amanda Glassman ◽  
...  
Keyword(s):  
National Health ◽  
Technology Assessment ◽  
Health Spending ◽  
Global Network ◽  
World Health ◽  
Health Coverage ◽  
Middle Income ◽  
Middle Income Countries ◽  
Public Money ◽  
Health Organization

The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) has increased the need for prioritizing health spending. Such need will soon accelerate as low- and middle-income countries transition from external aid. Countries will have to make difficult decisions on how best to integrate and finance previously donor-funded technologies and health services into their UHC packages in ways that are equitable, and operationally and financially sustainable. The International Decision Support Initiative (iDSI) is a global network of health, policy and economic expertise which supports countries in making better decisions about how best and how much to spend public money on healthcare. iDSI core partners include Center For Global Development, China National Health Development Research Center, Clinton Health Access Initiative, Health Intervention and Technology Assessment Program, Thailand / National Health Foundation, Imperial College London, Kenya Medical Research Institute, and the Norwegian Institute of Public Health. In May 2019, iDSI convened a roundtable entitled Why strengthening health systems to make better decisions is a Best Buy. The event brought together members of iDSI, development partners and other organizations working in the areas of evidence-informed priority-setting, resource allocation and purchasing. The roundtable participants identified key challenges and activities that could be undertaken by the broader health technology assessment (HTA) community to further country-led capacity building, as well to foster deeper collaboration between the community itself. HTA is a tool which can assist governments and development partners with evaluating alternative investment options in a defensible and accountable fashion. The definition and scope of HTA, and what it can achieve and support, can be presented more clearly and cohesively to stakeholders. Organizations engaging in HTA must develop deeper collaboration, and integrate existing collaborations, to ensure progress in developing HTA institutionalization globally is well organized and sustainable.

scholarly journals How can we make better health decisions: a Best Buy for all?

2020 ◽  
Vol 3 ◽  
pp. 1543
Author(s):  
Niki O'Brien ◽  
Ryan Li ◽  
Wanrudee Isaranuwatchai ◽  
Saudamini Vishwanath Dabak ◽  
Amanda Glassman ◽  
...  
Keyword(s):  
Priority Setting ◽  
Technology Assessment ◽  
Health Spending ◽  
Theory Of Change ◽  
Global Network ◽  
World Health ◽  
Health Coverage ◽  
Middle Income ◽  
World Health Assembly Resolution ◽  
Provider Payment

The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) requires them to prioritize health spending. Prioritizing is even more important as low- and middle-income countries transition from external aid. Countries will have difficult decisions to make on how best to integrate and finance previously donor-funded technologies and health services into their UHC packages in ways that are efficient and equitable, and operationally and financially sustainable. The International Decision Support Initiative (iDSI) is a global network of health, policy and economic expertise which supports countries in making better decisions about how best to spend public money on healthcare. In May 2019, iDSI convened a roundtable entitled Why strengthening health systems to make better decisions is a Best Buy. The event brought together members of iDSI, development partners and other organizations working in the areas of evidence-informed priority-setting, resource allocation, and purchasing. The roundtable participants identified key challenges and activities that could be undertaken by the broader health technology assessment (HTA) community: •           to develop a new publication package on premium estimation and budgeting, actuarial calculations and risk adjustment, provider payment modalities and monitoring of quality in service delivery •           to call on the WHO to redouble its efforts in accordance with the 2014 Health Intervention and Technology Assessment (HITA) World Health Assembly resolution to support countries in developing priority setting and HTA institutionalization, and to lead by example through introducing robust HTA processes in its own workings •             to develop a single Theory of Change (ToC) for evidence-informed priority setting, to be agreed by the major organizations working in the areas of priority setting and HTA.

scholarly journals Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data

Pharmacy ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 60
Author(s):  
Samantha Hollingworth ◽  
Therése Kairuz
Keyword(s):  
Anatomical Therapeutic Chemical ◽  
World Health ◽  
Defined Daily Dose ◽  
Health Coverage ◽  
Medicine Use ◽  
Real World Data ◽  
Middle Income ◽  
Middle Income Countries ◽  
Drug Utilization Studies ◽  
Health Organization

Medicines are essential for the treatment of acute, communicable, and non-communicable diseases. The World Health Organization developed a toolkit for drug (medicine) utilization studies to assist in reviewing and evaluating the prescribing, dispensing, and use of medicines. There is a growing need for rigorous studies of medicine use in low- and middle-income countries (LMIC) using standard approaches, especially in the context of universal health coverage. This commentary provides a succinct summary of how to use the WHO anatomical therapeutic chemical (ATC)/defined daily dose (DDD) methodology in pharmacoepidemiological studies, with a focus on LMIC contexts. We drew on information from WHO resources and published literature, citing examples and case studies. We encourage readers to publish their drug utilization studies, although we caution about predatory journals. We recommend the use of the RECORD-PE initiative which focuses on methods for doing pharmacoepidemiological research and evaluating the quality of published papers.

scholarly journals Comparative health system performance in six middle-income countries: cross-sectional analysis using World Health Organization study of global ageing and health

2017 ◽  
Vol 110 (9) ◽  
pp. 365-375 ◽  
Author(s):  
Riyadh Alshamsan ◽  
John Tayu Lee ◽  
Sangeeta Rana ◽  
Hasan Areabi ◽  
Christopher Millett
Keyword(s):  
Health System ◽  
System Performance ◽  
World Health ◽  
Health System Performance ◽  
Health Coverage ◽  
Cross Sectional ◽  
Middle Income ◽  
Middle Income Countries ◽  
Health Organization ◽  
Sectional Analysis

Objective To assess and compare health system performance across six middle-income countries that are strengthening their health systems in pursuit of universal health coverage. Design Cross-sectional analysis from the World Health Organization Study on global AGEing and adult health, collected between 2007 and 2010. Setting Six middle-income countries: China, Ghana, India, Mexico, Russia and South Africa. Participants Nationally representative sample of adults aged 50 years and older. Main outcome measures We present achievement against key indicators of health system performance across effectiveness, cost, access, patient-centredness and equity domains. Results We found areas of poor performance in prevention and management of chronic conditions, such as hypertension control and cancer screening coverage. We also found that cost remains a barrier to healthcare access in spite of insurance schemes. Finally, we found evidence of disparities across many indicators, particularly in the effectiveness and patient centredness domains. Conclusions These findings identify important focus areas for action and shared learning as these countries move towards achieving universal health coverage.

Defining Preterm Birth and Stillbirth in the Western Pacific: A Systematic Review

2021 ◽  
pp. 101053952110260
Author(s):  
Mairead Connolly ◽  
Laura Phung ◽  
Elise Farrington ◽  
Michelle J. L. Scoullar ◽  
Alyce N. Wilson ◽  
...  
Keyword(s):  
Preterm Birth ◽  
National Level ◽  
Health Indicators ◽  
Western Pacific ◽  
World Health ◽  
Middle Income ◽  
Middle Income Countries ◽  
Definition Of ◽  
Health Organization ◽  
The Impact

Preterm birth and stillbirth are important global perinatal health indicators. Definitions of these indicators can differ between countries, affecting comparability of preterm birth and stillbirth rates across countries. This study aimed to document national-level adherence to World Health Organization (WHO) definitions of preterm birth and stillbirth in the WHO Western Pacific region. A systematic search of government health websites and 4 electronic databases was conducted. Any official report or published study describing the national definition of preterm birth or stillbirth published between 2000 and 2020 was eligible for inclusion. A total of 58 data sources from 21 countries were identified. There was considerable variation in how preterm birth and stillbirth was defined across the region. The most frequently used lower gestational age threshold for viability of preterm birth was 28 weeks gestation (range 20-28 weeks), and stillbirth was most frequently classified from 20 weeks gestation (range 12-28 weeks). High-income countries more frequently used earlier gestational ages for preterm birth and stillbirth compared with low- to middle-income countries. The findings highlight the importance of clear, standardized, internationally comparable definitions for perinatal indicators. Further research is needed to determine the impact on regional preterm birth and stillbirth rates.

scholarly journals Tobacco Control in Low- and Middle-Income Countries: Changing the Present to Help the Future

2018 ◽  
Vol 13 (4) ◽  
pp. 187-188 ◽  
Author(s):  
Bethany Hipple Walters ◽  
Ionela Petrea ◽  
Harry Lando
Keyword(s):  
World Health Organization ◽  
World Health ◽  
Second Hand Smoke ◽  
Vulnerable Children ◽  
Middle Income ◽  
Middle Income Countries ◽  
The Past ◽  
Second Hand Smoke Exposure ◽  
Health Organization ◽  
Low And Middle Income

While the global smoking rate has dropped in the past 30 years (from 41.2% of men in 1980 to 31.1% in 2012 and from 10.6% of women in 1980 to 6.2% in 2012), the number of tobacco smokers has increased due to population growth (Ng et al., 2014). This tobacco use and second-hand smoke exposure continue to harm people worldwide. Those harmed are often vulnerable: children, those living in low- and middle-income countries (LMICs), those with existing diseases, etc. As noted by the World Health Organization (WHO), nearly 80% of those who smoke live in a LMIC (World Health Organization, 2017). Furthermore, it is often those who are more socio-economically disadvantaged or less educated in LMICs that are exposed to second-hand smoke at home and work (Nazar, Lee, Arora, & Millett, 2015).

scholarly journals Mental healthcare in Hungary: contradictions and possibilities

2010 ◽  
Vol 7 (2) ◽  
pp. 36-38 ◽  
Author(s):  
Tamás Kurimay
Keyword(s):  
Health Spending ◽  
Mental Healthcare ◽  
World Health ◽  
Minority Population ◽  
Official Language ◽  
The European Union ◽  
Middle Income ◽  
The Republic ◽  
Health Organization ◽  
The Uk

The Republic of Hungary is a landlocked country of 93000 km2 in central Europe; it is bordered by Austria, Slovakia, Ukraine, Romania, Serbia, Croatia and Slovenia. Its official language is Hungarian. Hungary joined the European Union (EU) in 2004. About 90% of the population of c. 10 million is ethnically Hungarian, with Roma comprising the largest minority population (6–8%). Currently classified as a middle-income country with a gross domestic product (GDP) of $191.7 billion (2007 figure), Hungary's total health spending accounted for 7.4% of GDP in 2007, less than the average of 8.9% among member states of the Organisation for Economic Co-operation and Development (OECD, 2009). The proportion of the total health budget for mental health is 5.1%, which is low when compared with, for instance, the UK (England and Wales 13.8%, Scotland 9.5%) (World Health Organization, 2008, p. 118, Fig. 8.1).

scholarly journals EXPLORING COVID-19 VACCINE ACCEPTANCE AND HESITANCY DETERMINANTS

2021 ◽  
Vol 03 (01) ◽  
pp. 80-91
Author(s):  
Tauheed Zahra ◽  
◽  
Farhan Ahmad Faiz ◽  
Farrah Ahmed ◽  
◽  
...  
Keyword(s):  
Educational Background ◽  
Vital Role ◽  
World Health ◽  
Vaccine Hesitancy ◽  
Social Worlds ◽  
Vaccine Acceptance ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low Middle Income Countries ◽  
Health Organization

The World Health Organization recognizes vaccine related myths and conspiracies as the world's top threat to public health safety, particularly in low middle-income countries. The current study aims to explore the beliefs of the general public towards the vaccine acceptance and the hesitancy. The study explicates the COVID 19 vaccine acceptance and hesitancy determinants through an in-depth qualitative approach. A total of 30 male and female millennials from different education backgrounds were interviewed through an interview guide. This study reveals that people have different beliefs related to the vaccine authenticity which plays a vital role in the reluctance towards it. Findings from paper is similar to literature that people from good educational background have similar thoughts towards COVID 19 vaccination. Disregard for the vaccine was caused by various factors, such as misinformation, safety concerns, and personal knowledge. This level of distrust was associated with the social worlds that participants experienced during the pandemic. COVID-19 vaccine hesitancy is a complex relationship that involves the spread of misinformation. Vaccine programs should provide a focused, localized, and empathetic response to counter misinformation. Keywords: COVID-19, vaccines, myths, hesitancy, vaccines awareness, pandemic, conspiracy, corona virus

scholarly journals Carbon Monoxide and Hydrocarbon Contains of Motorcycles: Metro Dumaguete, Philippines

2016 ◽  
Vol 25 (1) ◽  
Author(s):  
Narcisa T. Morallo
Keyword(s):  
Carbon Monoxide ◽  
World Health ◽  
Average Amount ◽  
Middle Income ◽  
Middle Income Countries ◽  
Safe Level ◽  
Emission Testing ◽  
Metro Manila ◽  
Standard Value ◽  
Health Organization

According to the World Health Organization (WHO), almost 98% of low and middle-income countries’ air fail to meet the United Nations (UN) body’s standards. Data from the Department of Environment and Natural Resources’ Environmental Management Bureau (DENR-EMB) revealed the Total Suspended Particles (TSP) in Metro Manila during the first quarter of 2015 reached 130 micrograms per normal cubic meter (ug/Ncm). The maximum safe level is 90 ug/Ncm. Since 80% of pollution load is contributed by vehicles, the study determined the amount of carbon monoxide (CO) and hydrocarbons (HC) during the smoke emission testing of motorcycles in Metro Dumaguete, Negros Oriental, Philippines. Random sampling and simple average formula were utilized in the study. Using the smoke test results from January to February 2015, it was found out that the average amount of CO is 1.45 µg/cm which is very low compared to DENR standard exposure value of 35 ug/cm for one hour and 10 µg/cm for 8-hour exposure. Also, the average amount of HC is 600.26 ppm which is low compared to DENR’s maximum set value of 4500ppm to 6500 ppm. Current findings indicate that the amount of CO of motorcycle emissions is insignificant while HC is low as compared to the standard value. 

Sign in / Sign up

Export Citation Format

Share Document